Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN)
Public ClinicalTrials.gov record NCT04146896. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the efficacy of NYX-2925 versus placebo in treating the neuropathic pain associated with diabetic peripheral neuropathy.
Study identification
- NCT ID
- NCT04146896
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 228 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 12, 2019 (Actual)
- Primary completion
- Feb 23, 2022 (Actual)
- Completion
- Feb 23, 2022 (Actual)
- Last update posted
- Apr 28, 2023
2019 – 2022
United States locations
- U.S. sites
- 35
- U.S. states
- 12
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Aptinyx Clinical Site | Fresno | California | 93720 | — |
| Aptinyx Clinical Site | Irvine | California | 92612 | — |
| Aptinyx Clinical Site | Lomita | California | 90717 | — |
| Aptinyx Clinical Site | Los Angeles | California | 90048 | — |
| Aptinyx Clinical Site | Norco | California | 92860 | — |
| Aptinyx Clinical Site | Pomona | California | 91767 | — |
| Aptinyx Clinical Site | Santa Ana | California | 92705 | — |
| Aptinyx Clinical Site | Tustin | California | 92780 | — |
| Aptinyx Clinical Site | Brandon | Florida | 33511 | — |
| Aptinyx Clinical Site | Clearwater | Florida | 33765 | — |
| Aptinyx Clinical Site | Greenacres City | Florida | 33467 | — |
| Aptinyx Clinical Site | Miami | Florida | 33126 | — |
| Aptinyx Clinical Site | Miami | Florida | 33144 | — |
| Aptinyx Clinical Site | New Port Richey | Florida | 34655 | — |
| Aptinyx Clinical Site | Tampa | Florida | 33615 | — |
| Aptinyx Clinical Site | Tampa | Florida | 33634 | — |
| Aptinyx Clinical Site | Winter Haven | Florida | 33880 | — |
| Aptinyx Clinical Site | Winter Park | Florida | 32789 | — |
| Aptinyx Clinical Site | Decatur | Georgia | 30030 | — |
| Aptinyx Clinical Site | Marietta | Georgia | 30060 | — |
| Aptinyx Clinical Site | Blackfoot | Idaho | 83221 | — |
| Aptinyx Clinical Site | Flossmoor | Illinois | 60422 | — |
| Aptinyx Clinical Site | Rochester | Michigan | 48307 | — |
| Aptinyx Clinical Site | Hazelwood | Missouri | 63042 | — |
| Aptinyx Clinical Site | Las Vegas | Nevada | 89123 | — |
| Aptinyx Clinical Site | Brooklyn | New York | 11235 | — |
| Aptinyx Clinical Site | New York | New York | 10036 | — |
| Aptinyx Clinical Site | Rochester | New York | 14618 | — |
| Aptinyx Clinical Site | Greenville | North Carolina | 27834 | — |
| Aptinyx Clinical Site | Winston-Salem | North Carolina | 27103 | — |
| Aptinyx Clinical Site | Duncansville | Pennsylvania | 16635 | — |
| Aptinyx Clinical Site | Houston | Texas | 77030 | — |
| Aptinyx Clinical Site | Mesquite | Texas | 75149 | — |
| Aptinyx Clinical Site | Plano | Texas | 75024 | — |
| Aptinyx Clinical Site | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04146896, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 28, 2023 · Synced Sep 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04146896 live on ClinicalTrials.gov.